These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 11597307

  • 1. A proton NMR study of the effect of a new intravasal injectable male contraceptive RISUG on seminal plasma metabolites.
    Sharma U, Chaudhury K, Jagannathan NR, Guha SK.
    Reproduction; 2001 Sep; 122(3):431-6. PubMed ID: 11597307
    [Abstract] [Full Text] [Related]

  • 2. Effect of a new injectable male contraceptive on the seminal plasma amino acids studied by proton NMR spectroscopy.
    Chaudhury K, Sharma U, Jagannathan NR, Guha SK.
    Contraception; 2002 Sep; 66(3):199-204. PubMed ID: 12384210
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A short-term evaluation of semen and accessory sex gland function in phase III trial subjects receiving intravasal contraceptive RISUG.
    Chaki SP, Das HC, Misro MM.
    Contraception; 2003 Jan; 67(1):73-8. PubMed ID: 12521662
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biophysical mechanism-mediated time-dependent effect on sperm of human and monkey vas implanted polyelectrolyte contraceptive.
    Guha SK.
    Asian J Androl; 2007 Mar; 9(2):221-7. PubMed ID: 17334590
    [Abstract] [Full Text] [Related]

  • 7. Studies on the membrane integrity of human sperm treated with a new injectable male contraceptive.
    Chaudhury K, Bhattacharyya AK, Guha SK.
    Hum Reprod; 2004 Aug; 19(8):1826-30. PubMed ID: 15192063
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety & efficacy of an intravasal, one-time injectable & non-hormonal male contraceptive (RISUG): A clinical experience.
    Sharma RS, Mathur AK, Singh R, Das HC, Singh GJ, Toor DPS, Guha SK.
    Indian J Med Res; 2019 Jul; 150(1):81-86. PubMed ID: 31571633
    [Abstract] [Full Text] [Related]

  • 10. Perspectives of contraceptive choices for men.
    Lohiya NK, Manivannan B, Bhande SS, Panneerdoss S, Garg S.
    Indian J Exp Biol; 2005 Nov; 43(11):1042-7. PubMed ID: 16313067
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relative suitability of DMSO and NaHCO3 for reversal of RISUG® induced long-term contraception.
    Ansari AS, Hussain M, Khan SR, Lohiya NK.
    Andrology; 2016 Mar; 4(2):306-13. PubMed ID: 26748683
    [Abstract] [Full Text] [Related]

  • 13. RISUG: an intravasal injectable male contraceptive.
    Lohiya NK, Alam I, Hussain M, Khan SR, Ansari AS.
    Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S63-72. PubMed ID: 25673546
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase II clinical trial of a vas deferens injectable contraceptive for the male.
    Guha SK, Singh G, Ansari S, Kumar S, Srivastava A, Koul V, Das HC, Malhotra RL, Das SK.
    Contraception; 1997 Oct; 56(4):245-50. PubMed ID: 9408706
    [Abstract] [Full Text] [Related]

  • 17. Safety evaluation of a male injectable antifertility agent, styrene maleic anhydride, in rats.
    Sethi N, Srivastava RK, Singh RK.
    Contraception; 1989 Feb; 39(2):217-26. PubMed ID: 2706990
    [Abstract] [Full Text] [Related]

  • 18. A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma.
    Averna TA, Kline EE, Smith AY, Sillerud LO.
    J Urol; 2005 Feb; 173(2):433-8. PubMed ID: 15643195
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.